ATOS
vs
U
USBC
ATOS
Over the past 12 months, ATOS has underperformed USBC, delivering a return of -56% compared to the USBC's +459 900% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ATOS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Atossa Therapeutics Inc
NASDAQ:ATOS
|
5.31
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.46
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ATOS, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Atossa Therapeutics Inc
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ATOS, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Atossa Therapeutics Inc
NASDAQ:ATOS
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ATOS, USBC
Performance Gap
ATOS, USBC
Performance By Year
ATOS, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
